These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20305716)

  • 21. Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red.
    Watson DJ; Lander AD; Selkoe DJ
    J Biol Chem; 1997 Dec; 272(50):31617-24. PubMed ID: 9395501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonphosphorylated tau slows down Aβ
    Beeg M; Battocchio E; De Luigi A; Colombo L; Natale C; Cagnotto A; Corbelli A; Fiordaliso F; Diomede L; Salmona M; Gobbi M
    J Biol Chem; 2021; 296():100664. PubMed ID: 33865852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-helix targeting reduces amyloid-beta peptide toxicity.
    Nerelius C; Sandegren A; Sargsyan H; Raunak R; Leijonmarck H; Chatterjee U; Fisahn A; Imarisio S; Lomas DA; Crowther DC; Strömberg R; Johansson J
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9191-6. PubMed ID: 19458258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology.
    Bett CK; Ngunjiri JN; Serem WK; Fontenot KR; Hammer RP; McCarley RL; Garno JC
    ACS Chem Neurosci; 2010 Sep; 1(9):608-26. PubMed ID: 22778850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide.
    Rezaei-Ghaleh N; Andreetto E; Yan LM; Kapurniotu A; Zweckstetter M
    PLoS One; 2011; 6(5):e20289. PubMed ID: 21633500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
    Sharoar MG; Thapa A; Shahnawaz M; Ramasamy VS; Woo ER; Shin SY; Park IS
    J Biomed Sci; 2012 Dec; 19(1):104. PubMed ID: 23259691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
    Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
    J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seed-induced acceleration of amyloid-β mediated neurotoxicity in vivo.
    Sowade RF; Jahn TR
    Nat Commun; 2017 Sep; 8(1):512. PubMed ID: 28894090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
    Sofola-Adesakin O; Khericha M; Snoeren I; Tsuda L; Partridge L
    Acta Neuropathol Commun; 2016 Oct; 4(1):109. PubMed ID: 27717375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid β structural polymorphism, associated toxicity and therapeutic strategies.
    Oren O; Taube R; Papo N
    Cell Mol Life Sci; 2021 Dec; 78(23):7185-7198. PubMed ID: 34643743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
    Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA
    FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly.
    Liao MC; Hoos MD; Aucoin D; Ahmed M; Davis J; Smith SO; Van Nostrand WE
    J Biol Chem; 2010 Nov; 285(46):35590-8. PubMed ID: 20807757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation.
    Liu B; Moloney A; Meehan S; Morris K; Thomas SE; Serpell LC; Hider R; Marciniak SJ; Lomas DA; Crowther DC
    J Biol Chem; 2011 Feb; 286(6):4248-56. PubMed ID: 21147772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginnalin A Inhibits Aggregation, Reverses Fibrillogenesis, and Alleviates Cytotoxicity of Amyloid β(1-42).
    Fan Q; Liu Y; Wang X; Zhang Z; Fu Y; Liu L; Wang P; Ma H; Ma H; Seeram NP; Zheng J; Zhou F
    ACS Chem Neurosci; 2020 Feb; 11(4):638-647. PubMed ID: 31967782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.
    Bokvist M; Lindström F; Watts A; Gröbner G
    J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.
    Lindberg DJ; Wesén E; Björkeroth J; Rocha S; Esbjörner EK
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1921-1929. PubMed ID: 28564579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice.
    Martins IC; Kuperstein I; Wilkinson H; Maes E; Vanbrabant M; Jonckheere W; Van Gelder P; Hartmann D; D'Hooge R; De Strooper B; Schymkowitz J; Rousseau F
    EMBO J; 2008 Jan; 27(1):224-33. PubMed ID: 18059472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
    Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
    J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.